Continuous and Quantitative Purification of T-Cell Subsets for Cell Therapy Manufacturing Using Magnetic Ratcheting Cytometry (AUDIO)

SLAS (Society for Laboratory Automation and Screening)

Caption

SLAS Technology author Coleman Murray, Ph.D., of UCLA talks about his contribution to the August 2018 special issue of SLAS Technology on Enabling Technology in Cell-Based Therapies. Murray's article illustrates an important example of how new technologies are changing automation and processing in cell therapy manufacturing.

Credit

SLAS

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.